Literature DB >> 31707038

The intricate relationship between diabetes, obesity and pancreatic cancer.

Silvano Paternoster1, Marco Falasca2.   

Abstract

Pancreatic cancer is one of the leading determinants of global cancer mortality, and its incidence is predicted to increase, to become in 2030 the second most common cause of cancer-related death. Obesity and diabetes are recognized risk factors for the development of pancreatic cancer. In the last few decades an epidemic of diabetes and obesity has been spreading worldwide, forewarning an increase in incidence of pancreatic cancer. This review considers the most recent literature, covering the multiple molecular axis linking these three pathologies, aiming to draw a more comprehensive view of pancreatic cancer for a better theragnostic stratification of the population.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exosomes; Inflammation; Obesity; Pancreatic cancer; Type 2 diabetes

Mesh:

Year:  2019        PMID: 31707038     DOI: 10.1016/j.bbcan.2019.188326

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  16 in total

1.  Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method.

Authors:  Lili Sheng; Hui Peng; Yang Pan; Chengci Wang; Yiping Zhu
Journal:  J Gastrointest Oncol       Date:  2020-10

2.  Folate Intake and Risk of Pancreatic Cancer: A Systematic Review and Updated Meta-Analysis of Epidemiological Studies.

Authors:  Hongjuan Fu; Jie Zeng; Chang Liu; Yi Gu; Yixin Zou; Hui Chang
Journal:  Dig Dis Sci       Date:  2020-08-08       Impact factor: 3.199

3.  Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.

Authors:  Yifang Hu; Ni Zeng; Yaoqi Ge; Dan Wang; Xiaoxuan Qin; Wensong Zhang; Feng Jiang; Yun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

4.  FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.

Authors:  Ying Chen; Peihui Liu; Di Shen; Han Liu; Lepeng Xu; Jian Wang; Daguang Shen; He Sun; Hongkui Wu
Journal:  Biol Open       Date:  2020-02-07       Impact factor: 2.422

5.  circRNA circ_102049 Implicates in Pancreatic Ductal Adenocarcinoma Progression through Activating CD80 by Targeting miR-455-3p.

Authors:  Jie Zhu; Yong Zhou; Shanshan Zhu; Fei Li; Jiajia Xu; Liming Zhang; Hairong Shu
Journal:  Mediators Inflamm       Date:  2021-01-07       Impact factor: 4.711

6.  Increased Risk of Hospitalization for Pancreatic Cancer in the First 8 Years after a Gestational Diabetes Mellitus regardless of Subsequent Type 2 Diabetes: A Nationwide Population-Based Study.

Authors:  Julien Simon; Karine Goueslard; Patrick Arveux; Sonia Bechraoui-Quantin; Jean-Michel Petit; Catherine Quantin
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

Review 7.  Diabetes and Pancreatic Cancer-A Dangerous Liaison Relying on Carbonyl Stress.

Authors:  Stefano Menini; Carla Iacobini; Martina Vitale; Carlo Pesce; Giuseppe Pugliese
Journal:  Cancers (Basel)       Date:  2021-01-16       Impact factor: 6.639

8.  Evaluation of the Efficacy of the Hospital Glycemic Management System for Patients with Malignant Tumors and Hyperglycemia.

Authors:  Juan Jiang; Danlan Pu; Renzhi Hu; Mingyang Hu; Qinan Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-16       Impact factor: 3.168

9.  Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients.

Authors:  Fanqin Bu; Xiaojian Zhu; Xuan Yi; Chen Luo; Kang Lin; Jinfeng Zhu; Cegui Hu; Zitao Liu; Jiefeng Zhao; Chao Huang; Wenjun Zhang; Jun Huang
Journal:  Onco Targets Ther       Date:  2020-11-06       Impact factor: 4.147

Review 10.  Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity.

Authors:  Bertrand Duvillié; Rayane Kourdoughli; Sabine Druillennec; Alain Eychène; Celio Pouponnot
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.